BNT-411

N/A

Report date: 2024/08/05 20:00:44
NME

Base Information

Drug NameBNT-411
Drug Alias NameBNT-411
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsSolid tumoursSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiontech Se
Active IndicationsN/A
Inactive IndicationsSolid tumoursSmall Cell Lung Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A